PRW: krenjp, I think you are to cynical even for the bar set by some small biotechs :-)
It can not be a 7 patient subset, because they list 8 specific events.
Perhapse the largest "disingenous" remark is that patients had failed all other treatments, which was simply not true. Most would not have had the current SOC (Avastin).
Market Data 
Markets 
AI
